Compass Pathways and Osmind Collaboration for Psychedelic Treatment Clinics
Compass Pathways has partnered with Osmind to enhance the readiness of independent clinics for administering psychedelic treatments if they receive FDA approval. This collaboration aims to guide small-to-medium sized clinics in effectively delivering these innovative therapies.
LONDON & NEW YORK–(BUSINESS WIRE)—- $CMPS #Biotech–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation announced today it has entered into a collaboration with Osmind, the platform powering a nationwide network of interventional psychiatry practices. This collaboration will inform how small-to-medium sized clinics nationwide can effectively deliver novel psychedelic treatments, if FDA approved. The agreement with Osmind further exp